Icares Medicus Inc Market Cap ($102.50 Million)
Market Cap & Net Worth: Icares Medicus Inc (6612)
Icares Medicus Inc market cap. Icares Medicus Inc (TWO:6612) has a market capitalization of $102.50 Million (NT$3.25 Billion) as of November 4, 2026. Listed on the TWO stock exchange, this Taiwan-based company holds position #18897 globally and #1051 in its home market, demonstrating a -0.58% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Icares Medicus Inc's stock price NT$69.00 by its total outstanding shares 47151584 (47.15 Million). Also see Icares Medicus Inc operating cash flow efficiency for how efficiently the company converts equity into cash flow.
Icares Medicus Inc Market Cap History (2016–2026)
Icares Medicus Inc market cap history from 2016 to 2026. Data shows growth from $70.18 Million to $102.50 Million (3.60% CAGR). Check 6612 stock price and chart for real-time trading data and today's change.
Icares Medicus Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Icares Medicus Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Icares Medicus Inc annual equity growth to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.10x
Icares Medicus Inc's market cap is 0.10 times its annual revenue
Latest Price to Earnings (P/E) Ratio
2.14x
Icares Medicus Inc's market cap is 2.14 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $75.19 Million | $266.05 Million | $31.25 Million | 0.28x | 2.41x |
| 2018 | $87.62 Million | $329.28 Million | $70.45 Million | 0.27x | 1.24x |
| 2019 | $126.32 Million | $419.36 Million | $81.02 Million | 0.30x | 1.56x |
| 2020 | $91.16 Million | $362.67 Million | $51.91 Million | 0.25x | 1.76x |
| 2021 | $100.84 Million | $393.92 Million | $58.60 Million | 0.26x | 1.72x |
| 2022 | $119.67 Million | $511.85 Million | $128.91 Million | 0.23x | 0.93x |
| 2023 | $187.18 Million | $605.45 Million | $97.73 Million | 0.31x | 1.92x |
| 2024 | $184.21 Million | $859.79 Million | $103.12 Million | 0.21x | 1.79x |
| 2025 | $109.78 Million | $1.13 Billion | $51.23 Million | 0.10x | 2.14x |
Competitor Companies of 6612 by Market Capitalization
Companies near Icares Medicus Inc in the global market cap rankings as of November 4, 2026. Also see Icares Medicus Inc balance sheet assets for a full breakdown of the balance sheet.
Key companies related to Icares Medicus Inc by market ranking:
- Intuitive Surgical Inc (NASDAQ:ISRG): Ranked #175 globally with a market cap of $132.26 Billion USD.
- EssilorLuxottica S. A. (PA:EL): Ranked #258 globally with a market cap of $99.74 Billion USD ( €85.32 Billion EUR).
- ESSILORLUXOTTICA 1/2/O.N. (F:ESLC): Ranked #418 globally with a market cap of $67.43 Billion USD ( €57.68 Billion EUR).
- HOYA CORP. ADR/ 1 O.N. (F:HYB0): Ranked #535 globally with a market cap of $50.37 Billion USD ( €43.09 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #175 | Intuitive Surgical Inc | NASDAQ:ISRG | $132.26 Billion | $440.75 |
| #258 | EssilorLuxottica S. A. | PA:EL | $99.74 Billion | €184.25 |
| #418 | ESSILORLUXOTTICA 1/2/O.N. | F:ESLC | $67.43 Billion | €91.50 |
| #535 | HOYA CORP. ADR/ 1 O.N. | F:HYB0 | $50.37 Billion | €150.00 |
Market Capitalization of Icares Medicus Inc (2016–2026)
Market capitalization of Icares Medicus Inc from 2016 to today. Between 2016 and today, Icares Medicus Inc's market cap moved from $70.18 Million to $ 102.50 Million, with a yearly change of 3.60%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | NT$102.50 Million | -6.63% |
| 2025 | NT$109.78 Million | -40.40% |
| 2024 | NT$184.21 Million | -1.59% |
| 2023 | NT$187.18 Million | +56.41% |
| 2022 | NT$119.67 Million | +18.68% |
| 2021 | NT$100.84 Million | +10.61% |
| 2020 | NT$91.16 Million | -27.83% |
| 2019 | NT$126.32 Million | +44.16% |
| 2018 | NT$87.62 Million | +16.53% |
| 2017 | NT$75.19 Million | +7.14% |
| 2016 | NT$70.18 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of Icares Medicus Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $102.50 Million USD |
| MoneyControl | $102.50 Million USD |
| MarketWatch | $102.50 Million USD |
| marketcap.company | $102.50 Million USD |
| Reuters | $102.50 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Icares Medicus Inc
ICARES Medicus, Inc., together with its subsidiaries, engages in the research, development, manufacturing, and sale of ophthalmic medical devices in Taiwan, the United States, United Kingdom, Japan, Spain, China, Germany, and internationally. The company is also involved in the manufacturing, sales, and service of intraocular lenses (IOLs) and its implantation systems for use in treating cataract… Read more